Co-Authors
This is a "connection" page, showing publications co-authored by BIYKEM BOZKURT and SANKAR NAVANEETHAN.
Connection Strength
0.536
-
Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice? JAMA. 2026 01 20; 335(3):217-219.
Score: 0.244
-
Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD. Clin J Am Soc Nephrol. 2025 Dec 01.
Score: 0.242
-
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
Score: 0.051